Legitimacy

What Happened to the Corinth Group Morepen Laboratories Deal?

In April 2021, Pytheas/Corinth announced a USD 100 million investment in Morepen Laboratories Ltd (BSE: 500288), an Indian pharmaceutical company.

As of December 2025, Corinth does not appear in Morepen's shareholding pattern filed with BSE/NSE. No evidence of the deal's completion has been found in any public filing.

This is the only verifiable investment deal publicly associated with the Corinth Group. The absence of evidence of completion — for a deal that would have been material to a BSE-listed company — is a critical red flag.

[Source: BSE/NSE filings, Morepen annual reports]

Related People

Related Entities

Related Investigations

Have You Been Affected?

If you have information about any of the people or entities described on this site, your account could help ongoing investigations and other affected parties.

Contact Us Confidentially